Activity ID
10129Expires
June 2, 2025Format Type
EnduringCME Credit
0.25Fee
30CME Provider: American Medical Association
Description of CME Course
Pharmacogenomics (or PGx) is a multidisciplinary aspect of health care that can provide more personalized treatment for patients. This approach to health care, while gaining interest at the provider level, requires the support of one’s institution to be a successful aspect of care. Implementation at the institutional level requires local PGx provider champions that can advocate for the needs of a PGx team/program. This module will discuss the key elements needed for a successful PGx program, the current challenges and barriers that PGx faces in hospital systems, and the future state of PGx.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Identify institutional barriers for implementing successful Pharmacogenomics programs
2. Recognize institutional perspectives of Pharmacogenomics implementation
3. Cite the educational opportunities in Pharmacogenomics
Keywords
Pharmacogenetics
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/ama.2021.0001572
